Skip to main content
Erschienen in: Inflammation 6/2013

01.12.2013

Reactive Oxygen Species in Peripheral Blood and Sputum Neutrophils During Bacterial and Nonbacterial Acute Exacerbation of Chronic Obstructive Pulmonary Disease

verfasst von: Mindaugas Vaitkus, Simona Lavinskiene, Diana Barkauskiene, Kristina Bieksiene, Jolanta Jeroch, Raimundas Sakalauskas

Erschienen in: Inflammation | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Chronic airway inflammation can be mediated by an enhanced neutrophil oxidative burst. However, the role of bacteria in the pathogenesis of chronic obstructive pulmonary disease (COPD) exacerbations is highly controversial. The aim of this study was to evaluate the production of reactive oxygen species (ROS) in peripheral blood and sputum neutrophils during bacterial and nonbacterial acute exacerbations of COPD (AECOPD). A total of 40 patients with AECOPD, 10 healthy nonsmokers, and 10 “healthy” smokers were enrolled into the study. Peripheral blood and sputum samples were obtained during exacerbation and after recovery. Neutrophils were isolated by high-density gradient centrifugation and magnetic separation. ROS production by neutrophils was investigated after stimulation with phorbol-myristate-acetate and Staphylococcus aureus bacteria. ROS production by neutrophils was assessed as the mean fluorescent intensity using a flow cytometer. IL-8 levels in serum and induced sputum were determinant by ELISA. Spontaneous ROS production was significantly higher in neutrophils from the patients with bacterial AECOPD as compared with nonbacterial AECOPD and stable COPD (P <0.05). ROS production stimulated with PMA and with Staphylococcus aureus was significantly higher in neutrophils isolated from the patients with bacterial AECOPD as compared with nonbacterial and stable COPD (P <0.05). The serum and induced sputum IL-8 levels were significantly increased in the patients with bacterial AECOPD than nonbacterial AECOPD, stable COPS, and “healthy” smokers and nonsmokers (P <0.05) and higher in the induced sputum as the compared with serum in all studied groups (P <0.05). Enlarge CRP level was documented during AECOPD than in all other groups (P <0.05). A markedly increased ROS production in sputum neutrophils during bacterial AECOPD shows an inflammatory response reflecting enhanced local inflammation, which can be mediated by bacterial colonization.
Literatur
1.
Zurück zum Zitat Rabe, K.F., S. Hurd, A. Anzueto, P.J. Barnes, S.A. Buist, P. Calverley, et al. 2007. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176(6): 532–555. Epub 2007/05/18.PubMedCrossRef Rabe, K.F., S. Hurd, A. Anzueto, P.J. Barnes, S.A. Buist, P. Calverley, et al. 2007. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176(6): 532–555. Epub 2007/05/18.PubMedCrossRef
2.
Zurück zum Zitat Boots, A.W., G.R. Haenen, and A. Bast. 2003. Oxidant metabolism in chronic obstructive pulmonary disease. The Eur Respir J Suppl. 46: 14s–27s. Epub 2003/11/19.CrossRef Boots, A.W., G.R. Haenen, and A. Bast. 2003. Oxidant metabolism in chronic obstructive pulmonary disease. The Eur Respir J Suppl. 46: 14s–27s. Epub 2003/11/19.CrossRef
3.
Zurück zum Zitat Guatura, S.B., J.A. Martinez, P.C. Santos Bueno, and M.L. Santos. 2000. Increased exhalation of hydrogen peroxide in healthy subjects following cigarette consumption. Revista Paulista de Medicina 118(4): 93–98.PubMedCrossRef Guatura, S.B., J.A. Martinez, P.C. Santos Bueno, and M.L. Santos. 2000. Increased exhalation of hydrogen peroxide in healthy subjects following cigarette consumption. Revista Paulista de Medicina 118(4): 93–98.PubMedCrossRef
4.
Zurück zum Zitat Koechlin, C., A. Couillard, J.P. Cristol, P. Chanez, M. Hayot, D. Le Gallais, et al. 2004. Does systemic inflammation trigger local exercise-induced oxidative stress in COPD? The Eur Respir J : Off J of the Eur Soc for Clin Respir Physiol 23(4): 538–544. Epub 2004/04/16.CrossRef Koechlin, C., A. Couillard, J.P. Cristol, P. Chanez, M. Hayot, D. Le Gallais, et al. 2004. Does systemic inflammation trigger local exercise-induced oxidative stress in COPD? The Eur Respir J : Off J of the Eur Soc for Clin Respir Physiol 23(4): 538–544. Epub 2004/04/16.CrossRef
5.
Zurück zum Zitat Langen, R.C., S.H. Korn, and E.F. Wouters. 2003. ROS in the local and systemic pathogenesis of COPD. Free Radic Biol Med 35(3): 226–235. Epub 2003/07/30.PubMedCrossRef Langen, R.C., S.H. Korn, and E.F. Wouters. 2003. ROS in the local and systemic pathogenesis of COPD. Free Radic Biol Med 35(3): 226–235. Epub 2003/07/30.PubMedCrossRef
6.
Zurück zum Zitat Oudijk, E.J., J.W. Lammers, and L. Koenderman. 2003. Systemic inflammation in chronic obstructive pulmonary disease. The Eur Respir J Suppl 46: 5s–13s. Epub 2003/11/19.CrossRef Oudijk, E.J., J.W. Lammers, and L. Koenderman. 2003. Systemic inflammation in chronic obstructive pulmonary disease. The Eur Respir J Suppl 46: 5s–13s. Epub 2003/11/19.CrossRef
7.
Zurück zum Zitat Sarir, H., P.A. Henricks, A.H. van Houwelingen, F.P. Nijkamp, and G. Folkerts. 2008. Cells, mediators and Toll-like receptors in COPD. Eur J Pharmacol 585(2–3): 346–353. Epub 2008/04/16.PubMedCrossRef Sarir, H., P.A. Henricks, A.H. van Houwelingen, F.P. Nijkamp, and G. Folkerts. 2008. Cells, mediators and Toll-like receptors in COPD. Eur J Pharmacol 585(2–3): 346–353. Epub 2008/04/16.PubMedCrossRef
8.
Zurück zum Zitat MacNee, W. 2001. Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 429(1–3): 195–207. Epub 2001/11/08.PubMedCrossRef MacNee, W. 2001. Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 429(1–3): 195–207. Epub 2001/11/08.PubMedCrossRef
9.
Zurück zum Zitat Drost, E.M., K.M. Skwarski, J. Sauleda, N. Soler, J. Roca, A. Agusti, et al. 2005. Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax 60(4): 293–300. Epub 2005/03/26.PubMedCrossRef Drost, E.M., K.M. Skwarski, J. Sauleda, N. Soler, J. Roca, A. Agusti, et al. 2005. Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax 60(4): 293–300. Epub 2005/03/26.PubMedCrossRef
10.
Zurück zum Zitat Noguera, A., S. Batle, C. Miralles, J. Iglesias, X. Busquets, W. MacNee, et al. 2001. Enhanced neutrophil response in chronic obstructive pulmonary disease. Thorax 56(6): 432–437. Epub 2001/05/22.PubMedCrossRef Noguera, A., S. Batle, C. Miralles, J. Iglesias, X. Busquets, W. MacNee, et al. 2001. Enhanced neutrophil response in chronic obstructive pulmonary disease. Thorax 56(6): 432–437. Epub 2001/05/22.PubMedCrossRef
11.
Zurück zum Zitat Rahman, I. 2005. Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms. Cell Biochem and Biophys 43(1): 167–188. Epub 2005/07/27.CrossRef Rahman, I. 2005. Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms. Cell Biochem and Biophys 43(1): 167–188. Epub 2005/07/27.CrossRef
12.
Zurück zum Zitat Sethi, S., C. Wrona, K. Eschberger, P. Lobbins, X. Cai, and T.F. Murphy. 2008. Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177(5): 491–497. Epub 2007/12/15.PubMedCrossRef Sethi, S., C. Wrona, K. Eschberger, P. Lobbins, X. Cai, and T.F. Murphy. 2008. Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177(5): 491–497. Epub 2007/12/15.PubMedCrossRef
13.
Zurück zum Zitat Zhang, X., H. Zheng, H. Zhang, W. Ma, F. Wang, C. Liu, et al. 2011. Increased interleukin (IL)-8 and decreased IL-17 production in chronic obstructive pulmonary disease (COPD) provoked by cigarette smoke. Cytokine 56(3): 717–725. Epub 2011/10/15.PubMedCrossRef Zhang, X., H. Zheng, H. Zhang, W. Ma, F. Wang, C. Liu, et al. 2011. Increased interleukin (IL)-8 and decreased IL-17 production in chronic obstructive pulmonary disease (COPD) provoked by cigarette smoke. Cytokine 56(3): 717–725. Epub 2011/10/15.PubMedCrossRef
14.
Zurück zum Zitat Pinto-Plata, V.M., H. Mullerova, J.F. Toso, M. Feudjo-Tepie, J.B. Soriano, R.S. Vessey, et al. 2006. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 61(1): 23–28. Epub 2005/09/07.PubMedCrossRef Pinto-Plata, V.M., H. Mullerova, J.F. Toso, M. Feudjo-Tepie, J.B. Soriano, R.S. Vessey, et al. 2006. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 61(1): 23–28. Epub 2005/09/07.PubMedCrossRef
15.
Zurück zum Zitat Anthonisen, N.R., J. Manfreda, C.P. Warren, E.S. Hershfield, G.K. Harding, and N.A. Nelson. 1987. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 106(2): 196–204. Epub 1987/02/01.PubMedCrossRef Anthonisen, N.R., J. Manfreda, C.P. Warren, E.S. Hershfield, G.K. Harding, and N.A. Nelson. 1987. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 106(2): 196–204. Epub 1987/02/01.PubMedCrossRef
16.
Zurück zum Zitat Seemungal, T.A., G.C. Donaldson, A. Bhowmik, D.J. Jeffries, and J.A. Wedzicha. 2000. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161(5): 1608–1613. Epub 2000/05/12.PubMedCrossRef Seemungal, T.A., G.C. Donaldson, A. Bhowmik, D.J. Jeffries, and J.A. Wedzicha. 2000. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161(5): 1608–1613. Epub 2000/05/12.PubMedCrossRef
17.
Zurück zum Zitat Miller, M.R., J. Hankinson, V. Brusasco, F. Burgos, R. Casaburi, A. Coates, et al. 2010. Standardisation of lung function testing: the authors' replies to readers' comments. The Eur Respir J : Off J of the Eur Soc for Clin Respir Physiol 36(6): 1496–1498. Epub 2010/12/02.CrossRef Miller, M.R., J. Hankinson, V. Brusasco, F. Burgos, R. Casaburi, A. Coates, et al. 2010. Standardisation of lung function testing: the authors' replies to readers' comments. The Eur Respir J : Off J of the Eur Soc for Clin Respir Physiol 36(6): 1496–1498. Epub 2010/12/02.CrossRef
18.
Zurück zum Zitat Hill, A.T., E.J. Campbell, S.L. Hill, D.L. Bayley, and R.A. Stockley. 2000. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med 109(4): 288–295.PubMedCrossRef Hill, A.T., E.J. Campbell, S.L. Hill, D.L. Bayley, and R.A. Stockley. 2000. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med 109(4): 288–295.PubMedCrossRef
19.
Zurück zum Zitat Murdoch, J.R., and C.M. Lloyd. 2010. Chronic inflammation and asthma. Mutat Res 690(1–2): 24–39. Epub 2009/09/23.PubMedCrossRef Murdoch, J.R., and C.M. Lloyd. 2010. Chronic inflammation and asthma. Mutat Res 690(1–2): 24–39. Epub 2009/09/23.PubMedCrossRef
20.
Zurück zum Zitat Terada, L.S. 2006. Specificity in reactive oxidant signaling: think globally, act locally. The J of Cell Biol 174(5): 615–623. Epub 2006/08/23.CrossRef Terada, L.S. 2006. Specificity in reactive oxidant signaling: think globally, act locally. The J of Cell Biol 174(5): 615–623. Epub 2006/08/23.CrossRef
21.
Zurück zum Zitat Tkacova, R., Z. Kluchova, P. Joppa, D. Petrasova, and A. Molcanyiova. 2007. Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD. Respir Med 101(8): 1670–1676. Epub 2007/04/24.PubMedCrossRef Tkacova, R., Z. Kluchova, P. Joppa, D. Petrasova, and A. Molcanyiova. 2007. Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD. Respir Med 101(8): 1670–1676. Epub 2007/04/24.PubMedCrossRef
22.
Zurück zum Zitat Babusyte, A., J. Jeroch, R. Stakauskas, and R. Sakalauskas. 2009. The production of reactive oxygen species in peripheral blood neutrophils is modulated by airway mucous. Central Eur J of Med 4(2): 245–252.CrossRef Babusyte, A., J. Jeroch, R. Stakauskas, and R. Sakalauskas. 2009. The production of reactive oxygen species in peripheral blood neutrophils is modulated by airway mucous. Central Eur J of Med 4(2): 245–252.CrossRef
23.
Zurück zum Zitat Sinden, N.J., and R.A. Stockley. 2010. Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence. Thorax. 65(10): 930–936. Epub 2010/07/16.PubMedCrossRef Sinden, N.J., and R.A. Stockley. 2010. Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence. Thorax. 65(10): 930–936. Epub 2010/07/16.PubMedCrossRef
24.
Zurück zum Zitat Floreani, A.A., T.A. Wyatt, J. Stoner, S.D. Sanderson, E.G. Thompson, D. Allen-Gipson, et al. 2003. Smoke and C5a induce airway epithelial intercellular adhesion molecule-1 and cell adhesion. Am J of Respir Cell Mol Biol 29(4): 472–482. Epub 2003/04/26.CrossRef Floreani, A.A., T.A. Wyatt, J. Stoner, S.D. Sanderson, E.G. Thompson, D. Allen-Gipson, et al. 2003. Smoke and C5a induce airway epithelial intercellular adhesion molecule-1 and cell adhesion. Am J of Respir Cell Mol Biol 29(4): 472–482. Epub 2003/04/26.CrossRef
25.
Zurück zum Zitat Hellermann, G.R., S.B. Nagy, X. Kong, R.F. Lockey, and S.S. Mohapatra. 2002. Mechanism of cigarette smoke condensate-induced acute inflammatory response in human bronchial epithelial cells. Respir Res 3: 22. Epub 2002/09/03.PubMedCrossRef Hellermann, G.R., S.B. Nagy, X. Kong, R.F. Lockey, and S.S. Mohapatra. 2002. Mechanism of cigarette smoke condensate-induced acute inflammatory response in human bronchial epithelial cells. Respir Res 3: 22. Epub 2002/09/03.PubMedCrossRef
26.
Zurück zum Zitat Vandivier, R.W., V.A. Fadok, P.R. Hoffmann, D.L. Bratton, C. Penvari, K.K. Brown, et al. 2002. Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. J Clin Invest 109(5): 661–670. Epub 2002/03/06.PubMed Vandivier, R.W., V.A. Fadok, P.R. Hoffmann, D.L. Bratton, C. Penvari, K.K. Brown, et al. 2002. Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. J Clin Invest 109(5): 661–670. Epub 2002/03/06.PubMed
27.
Zurück zum Zitat Shapiro, S.D. 1999. The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160(5 Pt 2): S29–S32. Epub 1999/11/11.PubMedCrossRef Shapiro, S.D. 1999. The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160(5 Pt 2): S29–S32. Epub 1999/11/11.PubMedCrossRef
28.
Zurück zum Zitat Wouters, E.F., K.H. Groenewegen, M.A. Dentener, and J.H. Vernooy. 2007. Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations. Proc Am Thorac Soc 4(8): 626–634. Epub 2007/12/13.PubMedCrossRef Wouters, E.F., K.H. Groenewegen, M.A. Dentener, and J.H. Vernooy. 2007. Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations. Proc Am Thorac Soc 4(8): 626–634. Epub 2007/12/13.PubMedCrossRef
29.
Zurück zum Zitat Salvi, S., A. Blomberg, B. Rudell, F. Kelly, T. Sandstrom, S.T. Holgate, et al. 1999. Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers. Am J Respir Crit Care Med 159(3): 702–709. Epub 1999/03/02.PubMedCrossRef Salvi, S., A. Blomberg, B. Rudell, F. Kelly, T. Sandstrom, S.T. Holgate, et al. 1999. Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers. Am J Respir Crit Care Med 159(3): 702–709. Epub 1999/03/02.PubMedCrossRef
30.
Zurück zum Zitat Terashima, T., M.E. Klut, D. English, J. Hards, J.C. Hogg, and S.F. van Eeden. 1999. Cigarette smoking causes sequestration of polymorphonuclear leukocytes released from the bone marrow in lung microvessels. Am J of Respir Cell Mol Biol 20(1): 171–177. Epub 1998/12/31.CrossRef Terashima, T., M.E. Klut, D. English, J. Hards, J.C. Hogg, and S.F. van Eeden. 1999. Cigarette smoking causes sequestration of polymorphonuclear leukocytes released from the bone marrow in lung microvessels. Am J of Respir Cell Mol Biol 20(1): 171–177. Epub 1998/12/31.CrossRef
31.
Zurück zum Zitat He, Z., Y. Chen, P. Chen, G. Wu, and S. Cai. 2010. Local inflammation occurs before systemic inflammation in patients with COPD. Respirology 15(3): 478–484. Epub 2010/03/10.PubMedCrossRef He, Z., Y. Chen, P. Chen, G. Wu, and S. Cai. 2010. Local inflammation occurs before systemic inflammation in patients with COPD. Respirology 15(3): 478–484. Epub 2010/03/10.PubMedCrossRef
32.
Zurück zum Zitat Heijink, I.H., S.M. Brandenburg, J.A. Noordhoek, D.J. Slebos, D.S. Postma, and A.J. van Oosterhout. 2011. Role of aberrant metalloproteinase activity in the pro-inflammatory phenotype of bronchial epithelium in COPD. Respir Res 12: 110. Epub 2011/08/25.PubMedCrossRef Heijink, I.H., S.M. Brandenburg, J.A. Noordhoek, D.J. Slebos, D.S. Postma, and A.J. van Oosterhout. 2011. Role of aberrant metalloproteinase activity in the pro-inflammatory phenotype of bronchial epithelium in COPD. Respir Res 12: 110. Epub 2011/08/25.PubMedCrossRef
33.
Zurück zum Zitat Atkinson, J.J., B.A. Lutey, Y. Suzuki, H.M. Toennies, D.G. Kelley, D.K. Kobayashi, et al. 2011. The role of matrix metalloproteinase-9 in cigarette smoke-induced emphysema. Am J Respir Crit Care Med 183(7): 876–884. Epub 2010/11/09.PubMedCrossRef Atkinson, J.J., B.A. Lutey, Y. Suzuki, H.M. Toennies, D.G. Kelley, D.K. Kobayashi, et al. 2011. The role of matrix metalloproteinase-9 in cigarette smoke-induced emphysema. Am J Respir Crit Care Med 183(7): 876–884. Epub 2010/11/09.PubMedCrossRef
34.
Zurück zum Zitat Babusyte, A., K. Stravinskaite, J. Jeroch, J. Lotvall, R. Sakalauskas, and B. Sitkauskiene. 2007. Patterns of airway inflammation and MMP-12 expression in smokers and ex-smokers with COPD. Respir Res 8: 81. Epub 2007/11/16.PubMedCrossRef Babusyte, A., K. Stravinskaite, J. Jeroch, J. Lotvall, R. Sakalauskas, and B. Sitkauskiene. 2007. Patterns of airway inflammation and MMP-12 expression in smokers and ex-smokers with COPD. Respir Res 8: 81. Epub 2007/11/16.PubMedCrossRef
35.
Zurück zum Zitat Anzueto, A., S. Sethi, and F.J. Martinez. 2007. Exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 4(7): 554–564. Epub 2007/09/20.PubMedCrossRef Anzueto, A., S. Sethi, and F.J. Martinez. 2007. Exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 4(7): 554–564. Epub 2007/09/20.PubMedCrossRef
36.
Zurück zum Zitat Franciosi, L.G., C.P. Page, B.R. Celli, M. Cazzola, M.J. Walker, M. Danhof, et al. 2006. Markers of disease severity in chronic obstructive pulmonary disease. Pulm Pharmacol & Ther 19(3): 189–199. Epub 2005/07/16.CrossRef Franciosi, L.G., C.P. Page, B.R. Celli, M. Cazzola, M.J. Walker, M. Danhof, et al. 2006. Markers of disease severity in chronic obstructive pulmonary disease. Pulm Pharmacol & Ther 19(3): 189–199. Epub 2005/07/16.CrossRef
37.
Zurück zum Zitat Olson, T.S., and K. Ley. 2002. Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol Regul Integr Comp Physiol 283(1): R7–R28. Epub 2002/06/19.PubMed Olson, T.S., and K. Ley. 2002. Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol Regul Integr Comp Physiol 283(1): R7–R28. Epub 2002/06/19.PubMed
38.
Zurück zum Zitat Patel, I.S., T.A. Seemungal, M. Wilks, S.J. Lloyd-Owen, G.C. Donaldson, and J.A. Wedzicha. 2002. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 57(9): 759–764. Epub 2002/08/30.PubMedCrossRef Patel, I.S., T.A. Seemungal, M. Wilks, S.J. Lloyd-Owen, G.C. Donaldson, and J.A. Wedzicha. 2002. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 57(9): 759–764. Epub 2002/08/30.PubMedCrossRef
39.
Zurück zum Zitat Weis, N., and T. Almdal. 2006. C-reactive protein—can it be used as a marker of infection in patients with exacerbation of chronic obstructive pulmonary disease? Eur J of Int Med 17(2): 88–91. Epub 2006/02/24.CrossRef Weis, N., and T. Almdal. 2006. C-reactive protein—can it be used as a marker of infection in patients with exacerbation of chronic obstructive pulmonary disease? Eur J of Int Med 17(2): 88–91. Epub 2006/02/24.CrossRef
Metadaten
Titel
Reactive Oxygen Species in Peripheral Blood and Sputum Neutrophils During Bacterial and Nonbacterial Acute Exacerbation of Chronic Obstructive Pulmonary Disease
verfasst von
Mindaugas Vaitkus
Simona Lavinskiene
Diana Barkauskiene
Kristina Bieksiene
Jolanta Jeroch
Raimundas Sakalauskas
Publikationsdatum
01.12.2013
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 6/2013
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-013-9690-3

Weitere Artikel der Ausgabe 6/2013

Inflammation 6/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.